NICE backs Lartruvo for soft tissue sarcoma
Patients with soft tissue sarcoma in England and Wales look set to win routine NHS access to Eli Lilly’s Lartruvo after cost regulators backed funding for the drug in draft guidelines.
Read More
Tag: STS
Lilly’s Lartruvo get EU nod for soft tissue sarcoma
Eli Lilly’s Lartruvo has received a conditional marketing approval by the European Commission to treat soft tissue sarcoma (STS).
Read More
Lilly’s Lartruvo bags US nod for soft tissue sarcoma
Eli Lilly’s Lartruvo has been approved by the US Food and Drug Administration to treat soft tissue sarcoma.
Read More
- Kainova reports positive results for DT‑9081 in advanced solid tumours
- EnteroBiotix completes enrolment for trial of EBX‑102‑02
- Lundbeck completes patient randomisation early in global MSA trial
- Incyte treatment for advanced anal cancer approved in Europe
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
